Clinical Trial Update: The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluated low molecular weight heparins in hepatocellular carcinoma. The update notes the study status as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Eastern Hepatobiliary Surgery Hospital | Conditions: Hepatocellular Carcinoma | Phase 2, Phase 3 | Status: COMPLETED